Cure Pharmaceutical, an Oxnard maker of thin, dissolvable strips for cannabis products, announced March 12 that it has received a license from the U.S. Drug Enforcement Administration naming it an authorized Schedule 1 substance manufacturer. The license is the first of its kind for an oral thin film company, Cure said. It allows the company…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
